about
Multidisciplinary meeting on male breast cancer: summary and research recommendationsMale breast cancer: risk factors, biology, diagnosis, treatment, and survivorshipThe effect of antineoplastic drugs in a male spontaneous mammary tumor modelCancer of the male breast.Clinical relevance of biologic factors in male breast cancer.Male breast cancer: a population-based comparison with female breast cancer.Endocrine therapy for male breast cancer: rates of toxicity and adherence.Carcinoma of the male breast.Rare case of male breast cancer and axillary lymphoma in the same patient: an unique case report.Male breast cancer: an update in diagnosis, treatment and molecular profilingObesity and male breast cancer: provocative parallels?Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration.Survival of male breast cancer in fars, South of iranLong-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.Male breast cancer: A retrospective study comparing survival with female breast cancerMale breast cancer: a gender issue.Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.Male breast cancer: a review of clinical management.Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report.Male breast cancer: is the scenario changing.CYP2D6 testing in breast cancer: ready for prime time?Computed tomographic lymphography for sentinel lymph node biopsy in male breast cancer: report of two casesExpression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancerDiagnosis and management of male breast cancer.Pharmacologic treatment of male breast cancer.Successful treatment of accessory breast cancer with endocrine therapy.Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype.Tamoxifen in men: a review of adverse events.Breast Cancer in Male Adolescents and Young Adults.Carcinoma of the male breast: update 1994.Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma.Endocrine treatment of physiological gynaecomastia.Carcinoma of the breast in males: a multiinstitutional survey.Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.Intracystic papillary carcinoma of the male breast: a case report.A case report of advanced male breast cancer with an objective response to tamoxifen treatment.Survival Comparisons Between Early Male and Female Breast Cancer Patients.Male breast cancer
P2860
Q24631800-5924B2E4-C232-4D19-86E3-81E02CECADA9Q27025244-0B25B3AD-FB6A-4C74-A834-27155701A092Q28533591-C72EFDD2-0EB4-4691-BE01-2110AA2B2BC2Q30306758-A880776E-8411-4A12-9931-8E9907D77FDAQ33183149-156F9A90-B933-4059-B8CF-CA5C5223E540Q33627779-4DD421DA-86AA-453E-ACA8-0D699BAFD750Q34171928-7E2D0A19-76F4-4E87-BA11-D52DEF43A3EAQ34678790-6642BB78-9DBB-4C3C-8E0E-32F24750266FQ35326899-B4E02ED1-2AFC-4C63-B5A3-5AF369514EBAQ35660943-D6A4243E-8033-48C8-89D4-F0792D9F733DQ35687528-EE8AD0AF-ECCB-4534-B437-E530D1097557Q35751733-F0135343-060D-4C67-BD72-35D24CE7B0CDQ36022290-62AA5736-48D3-4776-B4F1-737981886B3EQ36067806-1951AAC5-7CA3-4432-9E77-0665D0901850Q36078174-C7656511-76CE-4093-A1AA-AEC5EB0132A2Q36423949-204CAFE3-039B-4B76-B485-628ECE58D8DDQ36559277-21C5DB82-34F0-4677-96D2-2900274AF609Q36618815-684381A4-236D-4C3E-A7F5-2F9975169AC0Q36620532-FB311E5D-3D86-42E8-B5EC-2503B12508ABQ36657351-72AD8C31-D3E4-4265-A6EC-27AB0A4AD4ABQ36737005-62EE3E27-6A15-49AE-8568-0E9238F88329Q36836671-1CEB6C6B-36FC-4595-B5C8-BE660A777AFDQ37068971-D60E17DB-E8C9-47EE-82A8-FB69088DF65FQ37151073-46E3F654-5574-40E0-8D10-B65AE6AB662AQ37267326-355083E3-4DCE-4265-A4CD-712DB9E1C478Q37587223-F44E5CF0-61F9-41C0-A03E-3155D69B17D4Q37602852-4FC44766-15D0-41F8-B2CF-02EACF9C8865Q37699467-5AD217CB-A223-4C23-9EC2-AA7F9FB40F3DQ38827549-EC389ACD-02F0-4ED4-97B1-2D339E9C00EDQ39369046-E45A1FE9-1CA8-4CCC-8CA1-4CAC2F396C88Q40649404-569C4CD8-D6F0-4D14-8834-F62C7BE58C4DQ41529320-28F2A4FB-2EB8-4534-9BA5-38E62422270DQ42784993-12F01068-3094-4CC9-ABD1-D4FCB372734FQ44749173-4116786D-7518-4448-A6C0-4D70E3818608Q47591372-B0375979-AC83-4678-9648-E4E201DF264EQ48181860-16B692A4-0090-4447-90A1-372326CD3DE9Q53510700-1FB23DE5-4A8A-43B9-AC75-AB9DA6E70FB1Q55473188-3094370E-2F86-4244-A02E-1E704136888BQ57139827-07F1B5B9-D957-4435-AD5F-7D9008B4FC95
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Adjuvant tamoxifen for male breast cancer (MBC).
@ast
Adjuvant tamoxifen for male breast cancer (MBC).
@en
type
label
Adjuvant tamoxifen for male breast cancer (MBC).
@ast
Adjuvant tamoxifen for male breast cancer (MBC).
@en
prefLabel
Adjuvant tamoxifen for male breast cancer (MBC).
@ast
Adjuvant tamoxifen for male breast cancer (MBC).
@en
P2860
P356
P1476
Adjuvant tamoxifen for male breast cancer (MBC).
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1992.50
P407
P577
1992-02-01T00:00:00Z